53 research outputs found

    Response of Glacier Melt and Discharge to Future Climate Change, Susitna Basin, Alaska

    Get PDF
    A large dam for hydropower with a 67 km long reservoir is proposed in the Susitna basin, leading to multiple studies of the basin. This study focuses on the response of climate change of the Susitna basin glaciers and the effects on basin discharge

    Surface velocity and mass balance of Livingston Island ice cap, Antarctica

    Get PDF
    The mass budget of the ice caps surrounding the Antarctica Peninsula and, in particular, the partitioning of its main components are poorly known. Here we approximate frontal ablation (i.e. the sum of mass losses by calving and submarine melt) and surface mass balance of the ice cap of Livingston Island, the second largest island in the South Shetland Islands archipelago, and analyse variations in surface velocity for the period 2007–2011. Velocities are obtained from feature tracking using 25 PALSAR-1 images, and used in conjunction with estimates of glacier ice thicknesses inferred from principles of glacier dynamics and ground-penetrating radar observations to estimate frontal ablation rates by a flux-gate approach. Glacier-wide surface mass-balance rates are approximated from in situ observations on two glaciers of the ice cap. Within the limitations of the large uncertainties mostly due to unknown ice thicknesses at the flux gates, we find that frontal ablation (−509 ± 263 Mt yr−1, equivalent to −0.73 ± 0.38 m w.e. yr−1 over the ice cap area of 697 km2) and surface ablation (−0.73 ± 0.10 m w.e. yr−1) contribute similar shares to total ablation (−1.46 ± 0.39 m w.e. yr−1). Total mass change (δM = −0.67 ± 0.40 m w.e. yr−1) is negative despite a slightly positive surface mass balance (0.06 ± 0.14 m w.e. yr−1). We find large interannual and, for some basins, pronounced seasonal variations in surface velocities at the flux gates, with higher velocities in summer than in winter. Associated variations in frontal ablation (of ~237 Mt yr−1; −0.34 m w.e. yr−1) highlight the importance of taking into account the seasonality in ice velocities when computing frontal ablation with a flux-gate approach

    Gold nanoparticle distribution in polyelectrolyte brushes loaded at different pH conditions

    Get PDF
    Composites made of polymer brushes with inclusions of gold nanoparticles (AuNPs) combine the responsive nature of polymer brushes with the optical properties of the AuNPs, which offers the possibility to be used as colorimetric sensors. To this end, it is crucial to know how AuNPs are distributed inside the brush. Here, this distribution was elucidated by neutron reflectometry with contrast variation and a self-consistent reflectivity analysis based on the analytical parameterization of the volume fraction profiles of all chemical components. In contrast to former studies, this analysis allows the determination of the spatial distribution of components separately from each other: polyelectrolyte, AuNP, and water. Cationic poly-[2-(Methacryloyloxy) ethyl] trimethylammonium chloride (PMETAC) brushes were loaded with 5 nm AuNPs, which were coated with a pH-sensitive capping. The pH was varied during the incubation of the brush in the AuNP suspension. At a lower pH, AuNPs form aggregates in suspension and are attached to the brush periphery. They adsorb into the brush but do not fully penetrate it due to their bulkiness. At a higher pH, AuNP suspensions are electrostatically stabilized and the AuNPs penetrate the brush entirely. However, the AuNP distribution over the brush is not homogeneous but decreases gradually toward the substrate. Penetration of the AuNPs leads to a more extended conformation of the brush. According to the results of the detailed analysis of all components, an increase in water content could be excluded as a reason for brush swelling but replacement of water by the AuNP was observed

    Untangling effects of proteins as stabilizers for foam films

    Get PDF
    Foam film’s properties have a high impact on the properties of the macroscopic foams. This work focusses on protein stabilized foam films. The direct comparison of three different proteins with a concentration normalized to the protein surface enables to distinguish between electrostatic, steric and network stabilization effects. In order to untangle those effects, we study and compare two globular proteins (β − lactoglobulin, BLG, and bovine serum albumin, BSA) and a disordered, flexible protein (whole casein, CN) at low ionic strengths with varying solution pH. Image intensity measurement as a recently developed image analysis method in this field allows to record spatially resolved disjoining pressure isotherms in a Thin Film Pressure Balance (TFPB). This reveals insights into the structure formation in inhomogeneous protein films. As a novel method we introduce tracking inhomogeneities (features) which enables the measurement of interfacial mobility and stiffness of foam films. Around the isoelectric point (IEP), Newton Black Films (NBF) form which are stable for the globular proteins while they are unstable for the disordered flexible one. This difference in film stability is explained by different characteristics of the network structures which is supported by findings in the bulk and at the surface of the respective protein solutions

    ЧЕРНІГІВСЬКЕ ВИДАННЯ НОВОГО ЗАВІТУ 1717 РОКУ З ПРИСВЯТОЮ ГЕТЬМАНУ ІВАНУ СКОРОПАДСЬКОМУ

    Get PDF
    В умовах втрати більшості українських стародруків XVII – початку XVIII ст., неабияке значення для дослідження мають поодинокі знахідки, котрі іноді трапляються серед приватних зібрань або державних сховищ. Збереження і введення до наукового обігу подібних раритетів входить до важливих напрямків досліджень української історії козацької доби

    A novel multiplex detection array revealed systemic complement activation in oral squamous cell carcinoma

    Get PDF
    Oral squamous cell carcinoma (OSCC) is one of the most common tumors within the oral cavity. Early diagnosis and prognosis tools are urgently needed. This study aimed to investigate the activation of the complement system in OSCC patients as potential biomarker. Therefore, an innovative complement activation array was developed. Characterized antibodies detecting the complement activation specific epitopes C3a, C5a and sC5b-9 along with control antibodies were implemented into a suspension bead array. Human serum from a healthy (n = 46) and OSCC patient (n = 57) cohort were used to investigate the role of complement activation in oral tumor progression. The novel multiplex assay detected C3a, C5a and sC5b-9 from a minimal sample volume of human tears, aqueous humor and blood samples. Limits of detection were 0.04 ng/mL for C3a, 0.03 ng/mL for C5a and 18.9 ng/mL for sC5b-9, respectively. Biological cut-off levels guaranteed specific detections from serum. The mean serum concentration of a healthy control cohort was 680 ng/mL C3a, 70 ng/mL C5a and 2247 ng/mL sC5b-9, respectively. The assay showed an intra-assay precision of 2.9-6.4% and an inter-assay precision of 9.2-18.2%. Increased systemic C5a (p < 0.0001) and sC5b-9 (p = 0.01) concentrations in OSCC patients were determined using the validated multiplex complement assay. Higher C5a concentrations correlated with tumor differentiation and OSCC extension state. Systemic sC5b-9 determination provided a novel biomarker for infiltrating tumor growth and C3a levels were associated with local tumor spreading. Our study suggests that systemic complement activation levels in OSCC patients may be useful to assess disease progression

    Sirolimus inhibits key events of restenosis in vitro/ex vivo: evaluation of the clinical relevance of the data by SI/MPL- and SI/DES-ratio's

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Sirolimus (SRL, Rapamycin) has been used successfully to inhibit restenosis both in drug eluting stents (DES) and after systemic application. The current study reports on the effects of SRL in various human in vitro/ex vivo models and evaluates the theoretical clinical relevance of the data by SI/MPL- and SI/DES-ratio's.</p> <p>Methods</p> <p>Definition of the SI/MPL-ratio: relation between <b>s</b>ignificant <b>i</b>nhibitory effects in vitro/ex vivo and the <b>m</b>aximal <b>p</b>lasma <b>l</b>evel after systemic administration in vivo (6.4 ng/ml for SRL). Definition of the SI/DES-ratio: relation between <b>s</b>ignificant <b>i</b>nhibitory effects in vitro/ex vivo and the drug concentration in <b>DES </b>(7.5 mg/ml in the ISAR drug-eluting stent platform). Part I of the study investigated in cytoflow studies the effect of SRL (0.01–1000 ng/ml) on TNF-α induced expression of intercellular adhesion molecule 1 (ICAM-1) in human coronary endothelial cells (HCAEC) and human coronary smooth muscle cells (HCMSMC). Part II of the study analysed the effect of SRL (0.01–1000 ng/ml) on cell migration of HCMSMC. In part III, IV, and V of the study ex vivo angioplasty (9 bar) was carried out in a human organ culture model (HOC-model). SRL (50 ng/ml) was added for a period of 21 days, after 21 and 56 days cell proliferation, apoptosis, and neointimal hyperplasia was studied.</p> <p>Results</p> <p>Expression of ICAM-1 was significantly inhibited both in HCAEC (SRL ≥ 0.01 ng/ml) and HCMSMC (SRL ≥ 10 ng/ml). SRL in concentrations ≥ 0.1 ng/ml significantly inhibited migration of HCMSMC. Cell proliferation and neointimal hyperplasia was inhibited at day 21 and day 56, significance (p < 0.01) was achieved for the inhibitory effect on cell proliferation in the media at day 21. The number of apoptotic cells was always below 1%.</p> <p>Conclusion</p> <p>SI/MPL-ratio's ≤ 1 (ICAM-1 expression, cell migration) characterize inhibitory effects of SRL that can be theoretically expected both after systemic and local high dose administration, a SI/MPL-ratio of 7.81 (cell proliferation) represents an effect that was achieved with drug concentrations 7.81-times the MPL. SI/DES-ratio's between 10<sup>-6 </sup>and 10<sup>-8 </sup>indicate that the described inhibitory effects of SRL have been detected with micro to nano parts of the SRL concentration in the ISAR drug-eluting stent platform. Drug concentrations in DES will be a central issue in the future.</p
    corecore